Cipla CEO Umang Vohra on why Indian drugmakers must diversify
Advertisement

Cipla CEO Umang Vohra on why Indian drugmakers must diversify

By TEAM VCC

  • 27 Nov 2018

The Indian pharmaceutical industry has for long depended on generic drugs for expansion. But it's now time for the industry to go beyond the generics business, feels Umang Vohra, managing director and global CEO at Cipla. During a fireside chat with private equity firm ChrysCapital’s director Raghav Ramdev at the News Corp VCCircle Healthcare Investment Summit 2018, Vohra talked about the future of the generics business and the direction in which the country’s pharma industry is moving. Watch the full discussion.

Share article on

Advertisement
Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News